Reevaluation of the Japanese guideline for healthcare-associated pneumonia in a medium-sized community hospital in Japan

Journal of Infection and Chemotherapy

Volumn 19, Issue 4, 2013, Pages 579-587

  Oshitani, Yohei ^a   Nagai, Hideaki ^a   Matsui, Hirotoshi ^a   Aoshima, Masahiro ^b  

^a TOKYO NATIONAL HOSPITAL   (Japan)

^b KAMEDA MEDICAL CENTER   (Japan)

Author keywords

Drug resistant bacteria; Healthcare associated pneumonia; Keywords:: Severity of pneumonia; Nursing and healthcare associated pneumonia; Performance status

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; VANCOMYCIN;

ADROP SCORE; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMMUNITY HOSPITAL; DEHYDRATION; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; DISORIENTATION; DRUG TREATMENT FAILURE; FEMALE; GERIATRIC PATIENT; HUMAN; HYPOTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; NURSING CARE; PNEUMONIA; PRACTICE GUIDELINE; PROGNOSIS; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS, COMMUNITY; HUMANS; JAPAN; MALE; NURSING HOMES; ODDS RATIO; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84882237087     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0517-1     Document Type: Article

References (27)

1. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
2. Kollef MH, Morrow LE, Baughman RP, Craven DE, McGowan JE Jr, Micek ST, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes: proceedings of the HCAP Summit. Clin Infect Dis. 2008;46:S296-334.
3. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128:3854-62.
4. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother. 2007;51:3568-73.
5. Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J. 2001;18:362-8.
6. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64(suppl iii):1-55.
7. Carratalà J, Mykietiuk A, Fernández-Sabé N, Suárez C, Dorca J, Verdaguer R, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med. 2007;167:1393-9.
8. Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Hashimoto N, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest. 2009;135:633-40.
9. Maruyama T, Niederman MS, Kobayashi T, Kobayashi H, Takagi T, D'Alessandro-Gabazza CN, et al. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir Med. 2008;102:1287-95.
10. Tamiya N, Noguchi H, Nishi A, Reich MR, Ikegami N, Hashimoto H, et al. Population ageing and well-being: lessons from Japan's long-term care insurance policy. Lancet. 2011;378:1183-92.
11. Hashimoto H, Ikegami N, Shibuya K, Izumida N, Noguchi H, Yasunaga H, et al. Cost containment and quality of care in Japan: is there a trade-off? Lancet. 2011;378:1174-82.
12. Guidelines for the Management of Nursing and Healthcare-associated Pneumonia (NHCAP). Committee for Creation of Guidelines for Nursing and Healthcare-associated Pneumonia. Tokyo: Japanese Respiratory Society; 2011 (in Japanese).
13. Guidelines for the Management of Adult Community-acquired Pneumonia. Committee for Creation of Guidelines for Respiratory Infectious Diseases. Tokyo: Japanese Respiratory Society; 2007 (in Japanese).
14. Watanabe A, Goto H, Kohno S, Matsushima T, Abe S, Aoki N, et al. Nationwide survey on the 2005 guidelines for the management of community-acquired adult pneumonia: validation of severity assessment. Respir Invest. 2012;50(1):14-22.
15. Marrie TJ. Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect. 1992;24:247-55.
16. Marrie TJ, Durant H, Kwan C. Nursing home-acquired pneumonia. A case-control study. J Am Geriatr Soc. 1986;34:697-702.
17. Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, et al. Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital. Intern Med. 2012;51:585-94.
18. Drinka PJ, Gauerke C, Voeks S, Miller J, Schultz S, Krause P, et al. Pneumonia in a nursing home. J Gen Intern Med. 1994;9:650-2.
19. Zilberberg MD, Shorr AF, Micek ST, Mody SH, Kollef MH. Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest. 2008;134:963-8.
20. Park HK, Song JU, Um SW, Koh WJ, Suh GY, Chung MP, et al. Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respir Med. 2010;104:1729-35.
21. Venditti M, Falcone M, Corrao S, Licata G, Serra P. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med. 2009;150:19-26.
22. Brito V, Niederman MS. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis. 2009;22:316-25.
23. Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis. 2010;10:279-87.
24. Yende S, van der Poll T, Lee M, Huang DT, Newman AB. The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax. 2010;65:870-7.
25. Maruyama T, Taguchi O, Niederman MS, Morser J, Kobayashi H, Kobayashi T, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ. 2010;34:c1004.
26. Hedlund J, Hansson LO, Ortqvist A. Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors. Scand J Infect Dis. 1995;27:32-7.
27. Dennis MS, Lewis SC, Warlow C, FOOD Trial Collaboration. Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet. 2005;365:764-72.